187 related articles for article (PubMed ID: 9987917)
1. Biochemical basis of the beta-glucuronidase gene defect causing canine mucopolysaccharidosis VII.
Ray J; Scarpino V; Laing C; Haskins ME
J Hered; 1999; 90(1):119-23. PubMed ID: 9987917
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral vector-mediated beta-glucuronidase cDNA transfer to treat MPS VII RPE in vitro.
Verdugo ME; Scarpino V; Moullier P; Haskins ME; Aguirre GD; Ray J
Curr Eye Res; 2001 Nov; 23(5):357-67. PubMed ID: 11910525
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.
Sleeper MM; Fornasari B; Ellinwood NM; Weil MA; Melniczek J; O'Malley TM; Sammarco CD; Xu L; Ponder KP; Haskins ME
Circulation; 2004 Aug; 110(7):815-20. PubMed ID: 15289379
[TBL] [Abstract][Full Text] [Related]
4. Oral manifestations in patients and dogs with mucopolysaccharidosis Type VII.
Kantaputra PN; Smith LJ; Casal ML; Kuptanon C; Chang YC; Nampoothiri S; Paiyarom A; Veerasakulwong T; Trachoo O; Ketudat Cairns JR; Chinadet W; Tanpaiboon P
Am J Med Genet A; 2019 Mar; 179(3):486-493. PubMed ID: 30653816
[TBL] [Abstract][Full Text] [Related]
5. Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells.
Ray J; Bouvet A; DeSanto C; Fyfe JC; Xu D; Wolfe JH; Aguirre GD; Patterson DF; Haskins ME; Henthorn PS
Genomics; 1998 Mar; 48(2):248-53. PubMed ID: 9521879
[TBL] [Abstract][Full Text] [Related]
6. Retroviral cDNA transfer to the RPE: stable expression and modification of metabolism.
Ray J; Wolfe JH; Aguirre GD; Haskins ME
Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1658-66. PubMed ID: 9699555
[TBL] [Abstract][Full Text] [Related]
7. Characterization of beta-glucuronidase in the retinal pigment epithelium.
Ray J; Wu Y; Aguirre GD
Curr Eye Res; 1997 Feb; 16(2):131-43. PubMed ID: 9068944
[TBL] [Abstract][Full Text] [Related]
8. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
Zhu J; Kang W; Wolfe JH; Fraser NW
Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
[TBL] [Abstract][Full Text] [Related]
9. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
Mango RL; Xu L; Sands MS; Vogler C; Seiler G; Schwarz T; Haskins ME; Ponder KP
Mol Genet Metab; 2004 May; 82(1):4-19. PubMed ID: 15110316
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
Xu L; Mango RL; Sands MS; Haskins ME; Ellinwood NM; Ponder KP
Mol Ther; 2002 Dec; 6(6):745-58. PubMed ID: 12498771
[TBL] [Abstract][Full Text] [Related]
11. Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome).
Tomatsu S; Montaño AM; Dung VC; Grubb JH; Sly WS
Hum Mutat; 2009 Apr; 30(4):511-9. PubMed ID: 19224584
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnostic tests for ascertainment of genotype at the mucopolysaccharidosis type VII locus in dogs.
Ray J; Haskins ME; Ray K
Am J Vet Res; 1998 Sep; 59(9):1092-5. PubMed ID: 9736382
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII.
Gurda BL; De Guilhem De Lataillade A; Bell P; Zhu Y; Yu H; Wang P; Bagel J; Vite CH; Sikora T; Hinderer C; Calcedo R; Yox AD; Steet RA; Ruane T; O'Donnell P; Gao G; Wilson JM; Casal M; Ponder KP; Haskins ME
Mol Ther; 2016 Feb; 24(2):206-216. PubMed ID: 26447927
[TBL] [Abstract][Full Text] [Related]
14. A novel GUSB mutation in Brazilian terriers with severe skeletal abnormalities defines the disease as mucopolysaccharidosis VII.
Hytönen MK; Arumilli M; Lappalainen AK; Kallio H; Snellman M; Sainio K; Lohi H
PLoS One; 2012; 7(7):e40281. PubMed ID: 22815736
[TBL] [Abstract][Full Text] [Related]
15. Cross-correction of beta-glucuronidase deficiency by retroviral vector-mediated gene transfer.
Taylor RM; Wolfe JH
Exp Cell Res; 1994 Oct; 214(2):606-13. PubMed ID: 7925654
[TBL] [Abstract][Full Text] [Related]
16. Clinical response to persistent, low-level beta-glucuronidase expression in the murine model of mucopolysaccharidosis type VII.
Donsante A; Levy B; Vogler C; Sands MS
J Inherit Metab Dis; 2007 Apr; 30(2):227-38. PubMed ID: 17308887
[TBL] [Abstract][Full Text] [Related]
17. Mucopolysaccharidosis VII in a Cat Caused by 2 Adjacent Missense Mutations in the GUSB Gene.
Wang P; Sorenson J; Strickland S; Mingus C; Haskins ME; Giger U
J Vet Intern Med; 2015; 29(4):1022-8. PubMed ID: 26118695
[TBL] [Abstract][Full Text] [Related]
18. Transgene produces massive overexpression of human beta -glucuronidase in mice, lysosomal storage of enzyme, and strain-dependent tumors.
Vogler C; Galvin N; Levy B; Grubb J; Jiang J; Zhou XY; Sly WS
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2669-73. PubMed ID: 12591953
[TBL] [Abstract][Full Text] [Related]
19. Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs.
Wang B; O'Malley TM; Xu L; Vite C; Wang P; O'Donnell PA; Ellinwood NM; Haskins ME; Ponder KP
Mol Genet Metab; 2006 Jan; 87(1):8-21. PubMed ID: 16275036
[TBL] [Abstract][Full Text] [Related]
20. Corrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.
Serratrice N; Cubizolle A; Ibanes S; Mestre-Francés N; Bayo-Puxan N; Creyssels S; Gennetier A; Bernex F; Verdier JM; Haskins ME; Couderc G; Malecaze F; Kalatzis V; Kremer EJ
J Control Release; 2014 May; 181():22-31. PubMed ID: 24607662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
